{"sample_id": "pubmed_00001", "user_question": "在HER2阳性乳腺癌治疗中，皮下注射与静脉注射的疗效和安全性如何比较？", "expected_tools": [{"tool_name": "pubmed_search", "parameters": {"keywords": "\"breast cancer\" AND \"targeted therapy\" AND (\"clinical trial\" OR \"randomized controlled trial\") AND \"HER2\" AND", "limit": 5, "offset": 0}, "purpose": "检索相关医学文献"}], "evidence_pmids": ["32171426", "33357420"], "evidence_requirements": [{"pmid": "32171426", "title": "Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study.", "year": "2020", "venue": "The Lancet. Oncology", "abstract_evidence_sentence": "", "url": "https://pubmed.ncbi.nlm.nih.gov/32171426/"}, {"pmid": "33357420", "title": "Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection plus chemotherapy in HER2-positive early breast cancer (FeDeriCa): a randomised, open-label, multicentre, non-inferiority, phase 3 study.", "year": "2021", "venue": "The Lancet. Oncology", "abstract_evidence_sentence": "", "url": "https://pubmed.ncbi.nlm.nih.gov/33357420/"}], "answer_rubric": {"tool_rubrics": [{"category": "tool_use", "title": "正确调用 pubmed_search", "description": "模型必须调用 pubmed_search 工具进行文献检索，参数格式正确", "weight": 3}, {"category": "tool_use", "title": "引用正确的 PMID", "description": "输出必须包含正确的 PMID（至少 2 个），与工具返回结果对齐", "weight": 3}, {"category": "tool_use", "title": "提供年份和期刊信息", "description": "每篇被引用文献必须给出发表年份(year)和期刊名称(venue)", "weight": 2}, {"category": "tool_use", "title": "摘要证据句对齐", "description": "每篇被引用文献必须给出至少 1 句摘要证据句，可从 abstract 中摘写或紧贴改写", "weight": 3}], "content_rubrics": [{"category": "content", "title": "CLEOPATRA研究结果", "description": "模型应提到CLEOPATRA研究表明，使用pertuzumab、trastuzumab和docetaxel的组合显著改善了HER2阳性转移性乳腺癌患者的无进展生存期和总体生存率。", "weight": 3}, {"category": "content", "title": "FeDeriCa研究设计", "description": "模型应提到FeDeriCa研究是一项开放标签、多中心、非劣效性、3期研究，旨在评估皮下注射固定剂量组合与静脉注射方案在HER2阳性早期乳腺癌患者中的药代动力学、疗效和安全性。", "weight": 3}, {"category": "content", "title": "皮下注射方案批准", "description": "模型应提到皮下注射的pertuzumab和trastuzumab与重组人透明质酸酶的固定剂量组合于2020年6月29日被美国FDA批准用于HER2阳性早期乳腺癌。", "weight": 3}, {"category": "content", "title": "FeDeriCa研究的主要发现", "description": "模型应提到FeDeriCa研究的主要分析结果显示，皮下注射方案在疗效和安全性上与静脉注射方案相比不劣于后者。", "weight": 3}], "stability_strategy": {"strategy_type": "cache_snapshot", "description": "该样本依赖对 pubmed_search 返回做快照缓存", "implementation": "评测时使用缓存的证据库快照，避免实时 API 调用带来的漂移"}}, "metadata": {"query_used": "\"breast cancer\" AND \"targeted therapy\" AND (\"clinical trial\" OR \"randomized controlled trial\") AND \"HER2\" AND", "question_type": "比较", "language": "zh", "is_pagination_task": false, "evidence_snapshot_time": "2025-12-15T17:01:30.547414", "total_papers_available": 269, "num_tool_rubrics": 4, "num_content_rubrics": 4}}
{"sample_id": "pubmed_00002", "user_question": "What are the mechanisms of resistance to targeted therapies in HER2-positive and triple-negative breast cancer, and how do these mechanisms impact the efficacy of current treatment strategies?", "expected_tools": [{"tool_name": "pubmed_search", "parameters": {"keywords": "\"breast cancer\" AND \"targeted therapy\" AND \"mechanism\" AND (\"HER2\" OR \"BRCA1\" OR \"BRCA2\") AND", "limit": 5, "offset": 0}, "purpose": "检索相关医学文献"}], "evidence_pmids": ["27137076", "33507053", "36043521", "38630392"], "evidence_requirements": [{"pmid": "27137076", "title": "Breast Cancer: Current Molecular Therapeutic Targets and New Players.", "year": "2017", "venue": "Anti-cancer agents in medicinal chemistry", "abstract_evidence_sentence": "Breast cancer is the most common cancer and the most frequent cause of cancer death among women worldwide.", "url": "https://pubmed.ncbi.nlm.nih.gov/27137076/"}, {"pmid": "33507053", "title": "Targeted Cancer Therapies.", "year": "2021", "venue": "American family physician", "abstract_evidence_sentence": "Targeted cancer therapies involve chemotherapeutic agents that attack, directly or indirectly, a specific genetic biomarker found in a given cancer.", "url": "https://pubmed.ncbi.nlm.nih.gov/33507053/"}, {"pmid": "36043521", "title": "CDK4/6 inhibitor resistance mechanisms and treatment strategies (Review).", "year": "2022", "venue": "International journal of molecular medicine", "abstract_evidence_sentence": "In recent years, the incidence rate of breast cancer has increased year by year, and it has become a major threat to the health of women globally.", "url": "https://pubmed.ncbi.nlm.nih.gov/36043521/"}, {"pmid": "38630392", "title": "PI3K/AKT/mTOR signaling pathway: an important driver and therapeutic target in triple-negative breast cancer.", "year": "2024", "venue": "Breast cancer (Tokyo, Japan)", "abstract_evidence_sentence": "Triple-negative breast cancer (TNBC) is a highly heterogeneous tumor lacking estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression.", "url": "https://pubmed.ncbi.nlm.nih.gov/38630392/"}], "answer_rubric": {"tool_rubrics": [{"category": "tool_use", "title": "正确调用 pubmed_search", "description": "模型必须调用 pubmed_search 工具进行文献检索，参数格式正确", "weight": 3}, {"category": "tool_use", "title": "引用正确的 PMID", "description": "输出必须包含正确的 PMID（至少 2 个），与工具返回结果对齐", "weight": 3}, {"category": "tool_use", "title": "提供年份和期刊信息", "description": "每篇被引用文献必须给出发表年份(year)和期刊名称(venue)", "weight": 2}, {"category": "tool_use", "title": "摘要证据句对齐", "description": "每篇被引用文献必须给出至少 1 句摘要证据句，可从 abstract 中摘写或紧贴改写", "weight": 3}], "content_rubrics": [{"category": "content", "title": "HER2+靶向治疗药物", "description": "模型回答应提到HER2+乳腺癌的靶向治疗中使用的单克隆抗体，如曲妥珠单抗和帕妥珠单抗，并说明其靶向HER2的机制。", "weight": 3}, {"category": "content", "title": "TNBC的PI3K/AKT/mTOR通路", "description": "模型回答应提到在三阴性乳腺癌中，PI3K/AKT/mTOR信号通路的过度激活如何促进肿瘤生长、存活、增殖和血管生成。", "weight": 3}, {"category": "content", "title": "CDK4/6抑制剂耐药性", "description": "模型回答应讨论CDK4/6抑制剂在HR+/HER2-乳腺癌中的应用及其耐药性问题，并提到相关的临床试验发现。", "weight": 3}, {"category": "content", "title": "靶向治疗的生物标志物", "description": "模型回答应提到靶向癌症治疗中使用的特定基因生物标志物及其如何在治疗中起作用的例子。", "weight": 3}, {"category": "content", "title": "TNBC的侵袭性与预后", "description": "模型回答应提到三阴性乳腺癌的高侵袭性和转移性，以及由于缺乏有效治疗策略导致的预后不良。", "weight": 3}], "stability_strategy": {"strategy_type": "cache_snapshot", "description": "该样本依赖对 pubmed_search 返回做快照缓存", "implementation": "评测时使用缓存的证据库快照，避免实时 API 调用带来的漂移"}}, "metadata": {"query_used": "\"breast cancer\" AND \"targeted therapy\" AND \"mechanism\" AND (\"HER2\" OR \"BRCA1\" OR \"BRCA2\") AND", "question_type": "汇总", "language": "en", "is_pagination_task": false, "evidence_snapshot_time": "2025-12-15T17:01:33.991480", "total_papers_available": 190, "num_tool_rubrics": 4, "num_content_rubrics": 5}}
{"sample_id": "pubmed_00003", "user_question": "在乳腺癌的靶向治疗中，HER2扩增型乳腺癌（PMID: 24508693）与HER2低表达乳腺癌（PMID: 38291745）在治疗反应和预后方面有何不同？", "expected_tools": [{"tool_name": "pubmed_search", "parameters": {"keywords": "\"breast cancer\" AND \"targeted therapy\" AND \"review\" AND \"biomarkers\" AND", "limit": 5, "offset": 0}, "purpose": "检索相关医学文献"}], "evidence_pmids": ["24508693", "38291745"], "evidence_requirements": [{"pmid": "24508693", "title": "HER2 in breast cancer: a review and update.", "year": "2014", "venue": "Advances in anatomic pathology", "abstract_evidence_sentence": "HER2 (human epidermal growth factor receptor 2) receptor is a membrane tyrosine kinase and when activated affects cell proliferation and survival. The HER2 oncogene is located on chromosome 17q12.", "url": "https://pubmed.ncbi.nlm.nih.gov/24508693/"}, {"pmid": "38291745", "title": "HER2-Low Breast Cancer: Now and in the Future.", "year": "2024", "venue": "Cancer research and treatment", "abstract_evidence_sentence": "Breast cancer is a heterogeneous disease, and its subtypes are characterized by hormone receptor and human epidermal growth factor receptor 2 (HER2) expression status.", "url": "https://pubmed.ncbi.nlm.nih.gov/38291745/"}], "answer_rubric": {"tool_rubrics": [{"category": "tool_use", "title": "正确调用 pubmed_search", "description": "模型必须调用 pubmed_search 工具进行文献检索，参数格式正确", "weight": 3}, {"category": "tool_use", "title": "引用正确的 PMID", "description": "输出必须包含正确的 PMID（至少 2 个），与工具返回结果对齐", "weight": 3}, {"category": "tool_use", "title": "提供年份和期刊信息", "description": "每篇被引用文献必须给出发表年份(year)和期刊名称(venue)", "weight": 2}, {"category": "tool_use", "title": "摘要证据句对齐", "description": "每篇被引用文献必须给出至少 1 句摘要证据句，可从 abstract 中摘写或紧贴改写", "weight": 3}], "content_rubrics": [{"category": "content", "title": "HER2扩增的主要机制", "description": "模型应该提到HER2扩增是HER2受体过表达的主要途径，并且是乳腺癌中肿瘤发展和进展的主要驱动因素之一。", "weight": 3}, {"category": "content", "title": "HER2扩增在乳腺癌中的比例", "description": "模型应指出HER2扩增在乳腺癌中约占15%至20%的比例。", "weight": 3}, {"category": "content", "title": "HER2低表达的传统看法", "description": "模型应提到传统上认为HER2低表达乳腺癌不适合使用抗HER2靶向药物治疗，这基于曲妥珠单抗的三期试验结果。", "weight": 3}, {"category": "content", "title": "新型抗HER2药物的出现", "description": "模型应指出新型抗HER2抗体药物偶联物（如曲妥珠单抗-德鲁司特康）的出现，正在挑战传统对HER2低表达乳腺癌治疗的观点。", "weight": 3}, {"category": "content", "title": "HER2低表达的定义", "description": "模型应描述HER2低表达乳腺癌定义为免疫组化1+或2+且无基因扩增。", "weight": 3}], "stability_strategy": {"strategy_type": "cache_snapshot", "description": "该样本依赖对 pubmed_search 返回做快照缓存", "implementation": "评测时使用缓存的证据库快照，避免实时 API 调用带来的漂移"}}, "metadata": {"query_used": "\"breast cancer\" AND \"targeted therapy\" AND \"review\" AND \"biomarkers\" AND", "question_type": "比较", "language": "zh", "is_pagination_task": false, "evidence_snapshot_time": "2025-12-15T17:01:37.810512", "total_papers_available": 739, "num_tool_rubrics": 4, "num_content_rubrics": 5}}
{"sample_id": "pubmed_00004", "user_question": "在治疗肌萎缩侧索硬化症（ALS）中，CRISPR 基因编辑方法与传统基因治疗方法相比有哪些优势和限制？", "expected_tools": [{"tool_name": "pubmed_search", "parameters": {"keywords": "\"Amyotrophic Lateral Sclerosis\" AND CRISPR AND (\"gene editing\" OR \"genome editing\") AND (\"clinical trial\" OR \"treatment outcome\") AND \"\"[Date - Publication]", "limit": 5, "offset": 0}, "purpose": "检索相关医学文献"}], "evidence_pmids": ["33839324", "31991108"], "evidence_requirements": [{"pmid": "33839324", "title": "Gene therapy for ALS: A review.", "year": "2021", "venue": "Molecular therapy : the journal of the American Society of Gene Therapy", "abstract_evidence_sentence": "", "url": "https://pubmed.ncbi.nlm.nih.gov/33839324/"}, {"pmid": "31991108", "title": "Treatment of a Mouse Model of ALS by In Vivo Base Editing.", "year": "2020", "venue": "Molecular therapy : the journal of the American Society of Gene Therapy", "abstract_evidence_sentence": "Amyotrophic lateral sclerosis (ALS) is a debilitating and fatal disorder that can be caused by mutations in the superoxide dismutase 1 (SOD1) gene.", "url": "https://pubmed.ncbi.nlm.nih.gov/31991108/"}], "answer_rubric": {"tool_rubrics": [{"category": "tool_use", "title": "正确调用 pubmed_search", "description": "模型必须调用 pubmed_search 工具进行文献检索，参数格式正确", "weight": 3}, {"category": "tool_use", "title": "引用正确的 PMID", "description": "输出必须包含正确的 PMID（至少 2 个），与工具返回结果对齐", "weight": 3}, {"category": "tool_use", "title": "提供年份和期刊信息", "description": "每篇被引用文献必须给出发表年份(year)和期刊名称(venue)", "weight": 2}, {"category": "tool_use", "title": "摘要证据句对齐", "description": "每篇被引用文献必须给出至少 1 句摘要证据句，可从 abstract 中摘写或紧贴改写", "weight": 3}], "content_rubrics": [{"category": "content", "title": "ALS基因治疗挑战", "description": "描述ALS基因治疗面临的独特挑战，包括治疗靶点的缺乏和大脑与脊髓的难以接触。", "weight": 3}, {"category": "content", "title": "ALS基因治疗新进展", "description": "提到对ALS疾病机制和遗传学理解的进步如何与CNS靶向、基因递送、基因编辑和敲除技术的进展结合，开辟了新的治疗可能性。", "weight": 3}, {"category": "content", "title": "CRISPR在ALS中的应用", "description": "讨论CRISPR碱基编辑器如何通过创造无义突变永久禁用突变的SOD1基因表达，从而具有治疗ALS的潜力。", "weight": 3}, {"category": "content", "title": "AAV载体的限制", "description": "说明腺相关病毒（AAV）载体的限制性携带能力如何限制CRISPR基因编辑的治疗应用。", "weight": 3}, {"category": "content", "title": "SOD1突变的治疗", "description": "指出正在进行的ALS患者SOD1突变基因治疗临床试验以及CRISPR基因编辑在其中的潜在角色。", "weight": 3}, {"category": "content", "title": "转肽系统的创新", "description": "描述研究中建立的用于体内递送的内肽介导的转肽系统及其在克服AAV载体限制中的作用。", "weight": 3}], "stability_strategy": {"strategy_type": "cache_snapshot", "description": "该样本依赖对 pubmed_search 返回做快照缓存", "implementation": "评测时使用缓存的证据库快照，避免实时 API 调用带来的漂移"}}, "metadata": {"query_used": "\"Amyotrophic Lateral Sclerosis\" AND CRISPR AND (\"gene editing\" OR \"genome editing\") AND (\"clinical trial\" OR \"treatment outcome\") AND \"\"[Date - Publication]", "question_type": "比较", "language": "zh", "is_pagination_task": false, "evidence_snapshot_time": "2025-12-15T17:01:42.802080", "total_papers_available": 4, "num_tool_rubrics": 4, "num_content_rubrics": 6}}
{"sample_id": "pubmed_00005", "user_question": "通过CRISPR技术在ALS研究中的应用，哪些细胞机制或代谢途径被揭示为潜在的治疗靶点？", "expected_tools": [{"tool_name": "pubmed_search", "parameters": {"keywords": "\"Amyotrophic Lateral Sclerosis\" AND CRISPR AND (\"mechanism\" OR \"pathway\") AND \"\"[Date - Publication]", "limit": 5, "offset": 0}, "purpose": "检索相关医学文献"}], "evidence_pmids": ["33839324", "29562705", "39255192"], "evidence_requirements": [{"pmid": "33839324", "title": "Gene therapy for ALS: A review.", "year": "2021", "venue": "Molecular therapy : the journal of the American Society of Gene Therapy", "abstract_evidence_sentence": "", "url": "https://pubmed.ncbi.nlm.nih.gov/33839324/"}, {"pmid": "29562705", "title": "CRISPR/Cas9 Technology as an Emerging Tool for Targeting Amyotrophic Lateral Sclerosis (ALS).", "year": "2018", "venue": "International journal of molecular sciences", "abstract_evidence_sentence": "", "url": "https://pubmed.ncbi.nlm.nih.gov/29562705/"}, {"pmid": "39255192", "title": "DBT is a metabolic switch for maintenance of proteostasis under proteasomal impairment.", "year": "2024", "venue": "eLife", "abstract_evidence_sentence": "Proteotoxic stress impairs cellular homeostasis and underlies the pathogenesis of many neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS).", "url": "https://pubmed.ncbi.nlm.nih.gov/39255192/"}], "answer_rubric": {"tool_rubrics": [{"category": "tool_use", "title": "正确调用 pubmed_search", "description": "模型必须调用 pubmed_search 工具进行文献检索，参数格式正确", "weight": 3}, {"category": "tool_use", "title": "引用正确的 PMID", "description": "输出必须包含正确的 PMID（至少 2 个），与工具返回结果对齐", "weight": 3}, {"category": "tool_use", "title": "提供年份和期刊信息", "description": "每篇被引用文献必须给出发表年份(year)和期刊名称(venue)", "weight": 2}, {"category": "tool_use", "title": "摘要证据句对齐", "description": "每篇被引用文献必须给出至少 1 句摘要证据句，可从 abstract 中摘写或紧贴改写", "weight": 3}], "content_rubrics": [{"category": "content", "title": "ALS基因治疗挑战", "description": "描述ALS基因治疗面临的挑战，包括治疗靶点的缺乏和中枢神经系统的难以接触。", "weight": 3}, {"category": "content", "title": "CRISPR/Cas9在ALS中的应用", "description": "说明CRISPR/Cas9技术作为一种新兴工具在ALS研究中的应用，包括其作为RNA引导的DNA编辑工具的功能。", "weight": 3}, {"category": "content", "title": "SOD1和C9orf72基因突变", "description": "提到ALS患者中SOD1突变和C9orf72六核苷酸重复扩展的基因治疗临床试验正在进行中。", "weight": 3}, {"category": "content", "title": "蛋白质稳态的代谢开关", "description": "解释DBT作为蛋白质稳态的代谢开关，在蛋白酶体受损情况下的作用，特别是其在保护细胞免受蛋白酶体抑制相关细胞死亡中的角色。", "weight": 3}], "stability_strategy": {"strategy_type": "cache_snapshot", "description": "该样本依赖对 pubmed_search 返回做快照缓存", "implementation": "评测时使用缓存的证据库快照，避免实时 API 调用带来的漂移"}}, "metadata": {"query_used": "\"Amyotrophic Lateral Sclerosis\" AND CRISPR AND (\"mechanism\" OR \"pathway\") AND \"\"[Date - Publication]", "question_type": "汇总", "language": "zh", "is_pagination_task": false, "evidence_snapshot_time": "2025-12-15T17:01:46.419546", "total_papers_available": 49, "num_tool_rubrics": 4, "num_content_rubrics": 4}}
{"sample_id": "pubmed_pag_00006", "user_question": "近年来CRISPR技术在肌萎缩侧索硬化症（ALS）治疗中的应用现状与发展趋势是什么？", "expected_tools": [{"tool_name": "pubmed_search", "parameters": {"keywords": "\"Amyotrophic Lateral Sclerosis\" AND CRISPR AND \"review\"[Publication Type] AND \"\"[Date - Publication]", "limit": 5, "offset": 0}, "purpose": "检索相关医学文献"}, {"tool_name": "pubmed_search", "parameters": {"keywords": "\"Amyotrophic Lateral Sclerosis\" AND CRISPR AND \"review\"[Publication Type] AND \"\"[Date - Publication]", "limit": 5, "offset": 5}, "purpose": "获取第 2 页结果"}], "evidence_pmids": ["35269543", "33839324", "37483353", "39297377", "29562705"], "evidence_requirements": [{"pmid": "35269543", "title": "Comprehensive Research on Past and Future Therapeutic Strategies Devoted to Treatment of Amyotrophic Lateral Sclerosis.", "year": "2022", "venue": "International journal of molecular sciences", "abstract_evidence_sentence": "Amyotrophic lateral sclerosis (ALS) is a rapidly debilitating fatal neurodegenerative disorder, causing muscle atrophy and weakness, which leads to paralysis and eventual death.", "url": "https://pubmed.ncbi.nlm.nih.gov/35269543/"}, {"pmid": "33839324", "title": "Gene therapy for ALS: A review.", "year": "2021", "venue": "Molecular therapy : the journal of the American Society of Gene Therapy", "abstract_evidence_sentence": "", "url": "https://pubmed.ncbi.nlm.nih.gov/33839324/"}, {"pmid": "37483353", "title": "CRISPR/Cas9: implication for modeling and therapy of amyotrophic lateral sclerosis.", "year": "2023", "venue": "Frontiers in neuroscience", "abstract_evidence_sentence": "Amyotrophic lateral sclerosis (ALS) is a deadly neurological disease with a complicated and variable pathophysiology yet to be fully understood.", "url": "https://pubmed.ncbi.nlm.nih.gov/37483353/"}, {"pmid": "39297377", "title": "Extracellular vesicle and CRISPR gene therapy: Current applications in Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and Huntington's disease.", "year": "2024", "venue": "The European journal of neuroscience", "abstract_evidence_sentence": "Neurodegenerative diseases are characterized by progressive deterioration of the nervous system.", "url": "https://pubmed.ncbi.nlm.nih.gov/39297377/"}, {"pmid": "29562705", "title": "CRISPR/Cas9 Technology as an Emerging Tool for Targeting Amyotrophic Lateral Sclerosis (ALS).", "year": "2018", "venue": "International journal of molecular sciences", "abstract_evidence_sentence": "", "url": "https://pubmed.ncbi.nlm.nih.gov/29562705/"}], "answer_rubric": {"tool_rubrics": [{"category": "tool_use", "title": "正确调用 pubmed_search", "description": "模型必须调用 pubmed_search 工具进行文献检索，参数格式正确", "weight": 3}, {"category": "tool_use", "title": "引用正确的 PMID", "description": "输出必须包含正确的 PMID（至少 2 个），与工具返回结果对齐", "weight": 3}, {"category": "tool_use", "title": "提供年份和期刊信息", "description": "每篇被引用文献必须给出发表年份(year)和期刊名称(venue)", "weight": 2}, {"category": "tool_use", "title": "摘要证据句对齐", "description": "每篇被引用文献必须给出至少 1 句摘要证据句，可从 abstract 中摘写或紧贴改写", "weight": 3}], "content_rubrics": [{"category": "content", "title": "ALS的复杂病理机制", "description": "模型应描述ALS的多重病理机制，包括氧化应激、线粒体功能障碍、谷氨酸诱导的兴奋毒性和神经炎症等。", "weight": 3}, {"category": "content", "title": "基因治疗的最新进展", "description": "模型应提到ALS基因治疗的最新进展，包括SOD1突变和C9orf72六核苷酸重复扩展患者的临床试验。", "weight": 3}, {"category": "content", "title": "CRISPR/Cas9在ALS中的作用", "description": "模型应解释CRISPR/Cas9作为一种基因组编辑工具在ALS治疗中被广泛关注的原因，包括其新颖性、可行性和经济性。", "weight": 3}, {"category": "content", "title": "基因编辑的动物模型", "description": "模型应提到利用基因编辑技术创建的ALS动物模型在转化研究中的高预测价值。", "weight": 3}, {"category": "content", "title": "神经退行性疾病的复杂性", "description": "模型应讨论神经退行性疾病复杂的病理生理学如何导致诊断和治疗的困难。", "weight": 3}], "stability_strategy": {"strategy_type": "cache_snapshot", "description": "该样本依赖对 pubmed_search 返回做快照缓存", "implementation": "评测时使用缓存的证据库快照，避免实时 API 调用带来的漂移"}}, "metadata": {"query_used": "\"Amyotrophic Lateral Sclerosis\" AND CRISPR AND \"review\"[Publication Type] AND \"\"[Date - Publication]", "question_type": "趋势分析", "language": "zh", "is_pagination_task": true, "evidence_snapshot_time": "2025-12-15T17:01:49.951873", "total_papers_available": 53, "num_tool_rubrics": 4, "num_content_rubrics": 5}}
{"sample_id": "pubmed_00007", "user_question": "mRNA疫苗在传染病（如COVID-19和其他传染病）中的应用及其技术优势与传统疫苗相比有何不同？", "expected_tools": [{"tool_name": "pubmed_search", "parameters": {"keywords": "\"mRNA vaccine\" AND \"infectious disease\" AND (\"efficacy\" OR \"comparison\") AND (\"\"[Date - Publication])", "limit": 5, "offset": 0}, "purpose": "检索相关医学文献"}], "evidence_pmids": ["40075519", "38169577", "33921028"], "evidence_requirements": [{"pmid": "40075519", "title": "Revolutionizing immunization: a comprehensive review of mRNA vaccine technology and applications.", "year": "2025", "venue": "Virology journal", "abstract_evidence_sentence": "Messenger RNA (mRNA) vaccines have emerged as a transformative platform in modern vaccinology.", "url": "https://pubmed.ncbi.nlm.nih.gov/40075519/"}, {"pmid": "38169577", "title": "Nanoparticle technology for mRNA: Delivery strategy, clinical application and developmental landscape.", "year": "2024", "venue": "Theranostics", "abstract_evidence_sentence": "", "url": "https://pubmed.ncbi.nlm.nih.gov/38169577/"}, {"pmid": "33921028", "title": "mRNA-Based Vaccines.", "year": "2021", "venue": "Vaccines", "abstract_evidence_sentence": "Increases in the world's population and population density promote the spread of emerging pathogens. Vaccines are the most cost-effective means of preventing this spread.", "url": "https://pubmed.ncbi.nlm.nih.gov/33921028/"}], "answer_rubric": {"tool_rubrics": [{"category": "tool_use", "title": "正确调用 pubmed_search", "description": "模型必须调用 pubmed_search 工具进行文献检索，参数格式正确", "weight": 3}, {"category": "tool_use", "title": "引用正确的 PMID", "description": "输出必须包含正确的 PMID（至少 2 个），与工具返回结果对齐", "weight": 3}, {"category": "tool_use", "title": "提供年份和期刊信息", "description": "每篇被引用文献必须给出发表年份(year)和期刊名称(venue)", "weight": 2}, {"category": "tool_use", "title": "摘要证据句对齐", "description": "每篇被引用文献必须给出至少 1 句摘要证据句，可从 abstract 中摘写或紧贴改写", "weight": 3}], "content_rubrics": [{"category": "content", "title": "mRNA疫苗的高效开发", "description": "模型应提到mRNA疫苗具有快速临床开发和大规模生产的能力，这使其在应对COVID-19等传染病时具有显著优势。", "weight": 3}, {"category": "content", "title": "纳米技术在mRNA疫苗中的应用", "description": "模型应提到利用纳米技术，如脂质纳米颗粒，来提高mRNA疫苗的稳定性和递送效率，这对于其成功应用至关重要。", "weight": 3}, {"category": "content", "title": "mRNA疫苗的安全性", "description": "模型应提到mRNA疫苗不涉及感染性元素，因此相较于传统疫苗具有更高的安全性。", "weight": 3}, {"category": "content", "title": "mRNA疫苗的多样化应用", "description": "模型应提到mRNA疫苗不仅在传染病防治中有效，还在癌症和罕见疾病治疗中显示出潜力。", "weight": 3}, {"category": "content", "title": "传统疫苗开发的局限性", "description": "模型应提到传统疫苗在识别和生产新疫苗方面的不足，强调了新技术的必要性。", "weight": 3}], "stability_strategy": {"strategy_type": "cache_snapshot", "description": "该样本依赖对 pubmed_search 返回做快照缓存", "implementation": "评测时使用缓存的证据库快照，避免实时 API 调用带来的漂移"}}, "metadata": {"query_used": "\"mRNA vaccine\" AND \"infectious disease\" AND (\"efficacy\" OR \"comparison\") AND (\"\"[Date - Publication])", "question_type": "汇总", "language": "zh", "is_pagination_task": false, "evidence_snapshot_time": "2025-12-15T17:01:53.498266", "total_papers_available": 112, "num_tool_rubrics": 4, "num_content_rubrics": 5}}
{"sample_id": "pubmed_00008", "user_question": "mRNA疫苗在不同人群中的安全性和免疫原性是否存在差异？请比较mRNA-1273疫苗在青少年中的表现（PMID: 39836458）与其在孕妇中的表现（PMID: 34651406）。", "expected_tools": [{"tool_name": "pubmed_search", "parameters": {"keywords": "\"mRNA vaccine\" AND \"infectious disease\" AND \"epidemiology\" AND (\"\"[MeSH Terms] OR \"\"[MeSH Terms]) AND (\"\"[Date - Publication])", "limit": 5, "offset": 0}, "purpose": "检索相关医学文献"}], "evidence_pmids": ["39836458", "34651406"], "evidence_requirements": [{"pmid": "39836458", "title": "Safety and immunogenicity of an mRNA-1273 vaccine booster in adolescents.", "year": "2025", "venue": "Human vaccines & immunotherapeutics", "abstract_evidence_sentence": "Safety, immunogenicity, and effectiveness of an mRNA-1273 50-μg booster were evaluated in adolescents (12-17 years), with and without pre-booster SARS-CoV-2 infection.", "url": "https://pubmed.ncbi.nlm.nih.gov/39836458/"}, {"pmid": "34651406", "title": "COVID-19 and novel mRNA vaccines in pregnancy: an updated literature review.", "year": "2022", "venue": "BJOG : an international journal of obstetrics and gynaecology", "abstract_evidence_sentence": "The novel coronavirus, SARS-CoV-2, or COVID-19, has affected the world on a pandemic scale resulting in catastrophic outcomes and deaths.", "url": "https://pubmed.ncbi.nlm.nih.gov/34651406/"}], "answer_rubric": {"tool_rubrics": [{"category": "tool_use", "title": "正确调用 pubmed_search", "description": "模型必须调用 pubmed_search 工具进行文献检索，参数格式正确", "weight": 3}, {"category": "tool_use", "title": "引用正确的 PMID", "description": "输出必须包含正确的 PMID（至少 2 个），与工具返回结果对齐", "weight": 3}, {"category": "tool_use", "title": "提供年份和期刊信息", "description": "每篇被引用文献必须给出发表年份(year)和期刊名称(venue)", "weight": 2}, {"category": "tool_use", "title": "摘要证据句对齐", "description": "每篇被引用文献必须给出至少 1 句摘要证据句，可从 abstract 中摘写或紧贴改写", "weight": 3}], "content_rubrics": [{"category": "content", "title": "青少年mRNA-1273加强针安全性", "description": "模型应提到mRNA-1273 50-μg加强针在12-17岁青少年中的安全性评估结果。", "weight": 3}, {"category": "content", "title": "青少年免疫反应非劣效性", "description": "模型应提到mRNA-1273加强针在青少年中中和抗体反应的非劣效性比较结果。", "weight": 3}, {"category": "content", "title": "孕妇mRNA疫苗安全性数据", "description": "模型应提到目前关于mRNA疫苗在孕妇中的安全性数据有限。", "weight": 3}, {"category": "content", "title": "孕期疫苗接种决策因素", "description": "模型应提到孕妇及其医疗提供者在决定是否接种COVID-19疫苗时考虑的因素。", "weight": 3}, {"category": "content", "title": "孕妇疫苗风险不确定性", "description": "模型应提到mRNA疫苗对孕妇和胎儿的潜在风险目前尚不明确。", "weight": 3}], "stability_strategy": {"strategy_type": "cache_snapshot", "description": "该样本依赖对 pubmed_search 返回做快照缓存", "implementation": "评测时使用缓存的证据库快照，避免实时 API 调用带来的漂移"}}, "metadata": {"query_used": "\"mRNA vaccine\" AND \"infectious disease\" AND \"epidemiology\" AND (\"\"[MeSH Terms] OR \"\"[MeSH Terms]) AND (\"\"[Date - Publication])", "question_type": "比较", "language": "zh", "is_pagination_task": false, "evidence_snapshot_time": "2025-12-15T17:02:00.384997", "total_papers_available": 90, "num_tool_rubrics": 4, "num_content_rubrics": 5}}
{"sample_id": "pubmed_00009", "user_question": "循环肿瘤 DNA 作为食管癌诊断生物标志物的甲基化标记面板的诊断效能如何？", "expected_tools": [{"tool_name": "pubmed_search", "parameters": {"keywords": "\"circulating tumor DNA\" AND \"cancer diagnosis\" AND \"biomarker\" AND (\"effectiveness\" OR \"efficacy\") AND \"comparison\" AND", "limit": 5, "offset": 0}, "purpose": "检索相关医学文献"}], "evidence_pmids": ["39725880"], "evidence_requirements": [{"pmid": "39725880", "title": "Detection of a novel DNA methylation marker panel for esophageal cancer diagnosis using circulating tumor DNA.", "year": "2024", "venue": "BMC cancer", "abstract_evidence_sentence": "BACKGROUND\nEsophageal cancer (ECa) is one of the most deadly cancers, with increasing incidence worldwide and poor prognosis.", "url": "https://pubmed.ncbi.nlm.nih.gov/39725880/"}], "answer_rubric": {"tool_rubrics": [{"category": "tool_use", "title": "正确调用 pubmed_search", "description": "模型必须调用 pubmed_search 工具进行文献检索，参数格式正确", "weight": 3}, {"category": "tool_use", "title": "引用正确的 PMID", "description": "输出必须包含正确的 PMID（至少 1 个），与工具返回结果对齐", "weight": 3}, {"category": "tool_use", "title": "提供年份和期刊信息", "description": "每篇被引用文献必须给出发表年份(year)和期刊名称(venue)", "weight": 2}, {"category": "tool_use", "title": "摘要证据句对齐", "description": "每篇被引用文献必须给出至少 1 句摘要证据句，可从 abstract 中摘写或紧贴改写", "weight": 3}], "content_rubrics": [{"category": "content", "title": "食管癌诊断挑战", "description": "提到食管癌的高致死率、发病率上升以及预后不良的背景信息。", "weight": 3}, {"category": "content", "title": "内镜筛查的局限性", "description": "讨论内镜作为高危人群检测手段的侵入性和不便性，导致其不适合大规模筛查。", "weight": 3}, {"category": "content", "title": "新甲基化标记面板", "description": "描述研究中开发的用于血液检测的基因甲基化标记面板。", "weight": 3}, {"category": "content", "title": "研究参与者概况", "description": "提到研究中使用的304名参与者的构成，包括203例病例和101名对照。", "weight": 3}, {"category": "content", "title": "甲基化标记物评估", "description": "具体指出研究中评估的DNA甲基化标记物，包括SEPTIN9和TFPI2。", "weight": 3}], "stability_strategy": {"strategy_type": "cache_snapshot", "description": "该样本依赖对 pubmed_search 返回做快照缓存", "implementation": "评测时使用缓存的证据库快照，避免实时 API 调用带来的漂移"}}, "metadata": {"query_used": "\"circulating tumor DNA\" AND \"cancer diagnosis\" AND \"biomarker\" AND (\"effectiveness\" OR \"efficacy\") AND \"comparison\" AND", "question_type": "抽取", "language": "zh", "is_pagination_task": false, "evidence_snapshot_time": "2025-12-15T17:02:12.516812", "total_papers_available": 1, "num_tool_rubrics": 4, "num_content_rubrics": 5}}
{"sample_id": "pubmed_00010", "user_question": "How does the analysis of circulating tumor DNA (ctDNA) as a biomarker for minimal residual disease (MRD) in solid tumors contribute to personalized cancer diagnosis and therapy?", "expected_tools": [{"tool_name": "pubmed_search", "parameters": {"keywords": "\"circulating tumor DNA\" AND \"cancer diagnosis\" AND \"biomarker\" AND \"mechanism\" AND \"molecular\" AND", "limit": 5, "offset": 0}, "purpose": "检索相关医学文献"}], "evidence_pmids": ["34868984"], "evidence_requirements": [{"pmid": "34868984", "title": "Circulating Tumor DNA and Minimal Residual Disease (MRD) in Solid Tumors: Current Horizons and Future Perspectives.", "year": "2021", "venue": "Frontiers in oncology", "abstract_evidence_sentence": "Circulating tumor DNA (ctDNA) is cell-free DNA (cfDNA) fragment in the bloodstream that originates from malignant tumors or circulating tumor cells.", "url": "https://pubmed.ncbi.nlm.nih.gov/34868984/"}], "answer_rubric": {"tool_rubrics": [{"category": "tool_use", "title": "正确调用 pubmed_search", "description": "模型必须调用 pubmed_search 工具进行文献检索，参数格式正确", "weight": 3}, {"category": "tool_use", "title": "引用正确的 PMID", "description": "输出必须包含正确的 PMID（至少 1 个），与工具返回结果对齐", "weight": 3}, {"category": "tool_use", "title": "提供年份和期刊信息", "description": "每篇被引用文献必须给出发表年份(year)和期刊名称(venue)", "weight": 2}, {"category": "tool_use", "title": "摘要证据句对齐", "description": "每篇被引用文献必须给出至少 1 句摘要证据句，可从 abstract 中摘写或紧贴改写", "weight": 3}], "content_rubrics": [{"category": "content", "title": "ctDNA的基本定义", "description": "模型应解释ctDNA是来源于恶性肿瘤或循环肿瘤细胞的血液中无细胞DNA片段。", "weight": 3}, {"category": "content", "title": "ctDNA作为生物标志物的作用", "description": "模型应提到ctDNA作为临床肿瘤学中的一种有前景的非侵入性生物标志物。", "weight": 3}, {"category": "content", "title": "ctDNA在个体化癌症诊断中的应用", "description": "模型应讨论ctDNA分析如何为多种类型肿瘤的个性化癌症诊断和治疗开辟新途径。", "weight": 3}, {"category": "content", "title": "MRD与疾病复发的关系", "description": "模型应指出最小残留病灶（MRD）与疾病复发密切相关。", "weight": 3}, {"category": "content", "title": "ctDNA用于MRD检测的研究重点", "description": "模型应描述使用ctDNA识别特定遗传和分子改变作为新型MRD检测靶点的研究重点。", "weight": 3}], "stability_strategy": {"strategy_type": "cache_snapshot", "description": "该样本依赖对 pubmed_search 返回做快照缓存", "implementation": "评测时使用缓存的证据库快照，避免实时 API 调用带来的漂移"}}, "metadata": {"query_used": "\"circulating tumor DNA\" AND \"cancer diagnosis\" AND \"biomarker\" AND \"mechanism\" AND \"molecular\" AND", "question_type": "汇总", "language": "en", "is_pagination_task": false, "evidence_snapshot_time": "2025-12-15T17:02:15.835990", "total_papers_available": 1, "num_tool_rubrics": 4, "num_content_rubrics": 5}}
{"sample_id": "pubmed_00011", "user_question": "How does the epigenetic regulation via the STING-PERK pathway compare to post-translational modifications by HDACs in the context of cardiovascular disease mechanisms?", "expected_tools": [{"tool_name": "pubmed_search", "parameters": {"keywords": "\"epigenetic regulation\" AND \"cardiovascular disease\" AND \"mechanism\" AND [Publication Date]", "limit": 5, "offset": 0}, "purpose": "检索相关医学文献"}], "evidence_pmids": ["38045042", "40710369"], "evidence_requirements": [{"pmid": "38045042", "title": "Non-canonical STING-PERK pathway dependent epigenetic regulation of vascular endothelial dysfunction via integrating IRF3 and NF- κ B in inflammatory response.", "year": "2023", "venue": "Acta pharmaceutica Sinica. B", "abstract_evidence_sentence": "Inflammation-driven endothelial dysfunction is the major initiating factor in atherosclerosis, while the underlying mechanism remains elusive.", "url": "https://pubmed.ncbi.nlm.nih.gov/38045042/"}, {"pmid": "40710369", "title": "HDACs and Their Inhibitors on Post-Translational Modifications: The Regulation of Cardiovascular Disease.", "year": "2025", "venue": "Cells", "abstract_evidence_sentence": "Cardiovascular diseases (CVD), such as myocardial hypertrophy, heart failure, atherosclerosis, and myocardial ischemia/reperfusion (I/R) injury, are among the major threats to human health worldwide.", "url": "https://pubmed.ncbi.nlm.nih.gov/40710369/"}], "answer_rubric": {"tool_rubrics": [{"category": "tool_use", "title": "正确调用 pubmed_search", "description": "模型必须调用 pubmed_search 工具进行文献检索，参数格式正确", "weight": 3}, {"category": "tool_use", "title": "引用正确的 PMID", "description": "输出必须包含正确的 PMID（至少 2 个），与工具返回结果对齐", "weight": 3}, {"category": "tool_use", "title": "提供年份和期刊信息", "description": "每篇被引用文献必须给出发表年份(year)和期刊名称(venue)", "weight": 2}, {"category": "tool_use", "title": "摘要证据句对齐", "description": "每篇被引用文献必须给出至少 1 句摘要证据句，可从 abstract 中摘写或紧贴改写", "weight": 3}], "content_rubrics": [{"category": "content", "title": "STING-PERK在动脉粥样硬化中的作用", "description": "模型应提到STING-PERK通路在动脉粥样硬化中的显著激活，并整合IRF3和NF-κB信号以促进炎症反应。", "weight": 3}, {"category": "content", "title": "HDACs在心血管疾病中的调节作用", "description": "模型应提到HDACs通过后翻译修饰对心血管疾病的调节，涉及心肌肥大、心力衰竭等疾病。", "weight": 3}, {"category": "content", "title": "非经典STING-PERK通路的独特性", "description": "模型应提到非经典STING-PERK通路的独特激活模式，与传统STING信号途径的差异。", "weight": 3}, {"category": "content", "title": "后翻译修饰对蛋白质功能的影响", "description": "模型应提到后翻译修饰如何通过动态化学修饰影响蛋白质功能，维持心血管系统的稳态。", "weight": 3}, {"category": "content", "title": "HDACs对心血管病理状态的影响", "description": "模型应提到HDACs与心血管病理状态的密切关系，尤其是其在病理生理过程中的关键作用。", "weight": 3}], "stability_strategy": {"strategy_type": "cache_snapshot", "description": "该样本依赖对 pubmed_search 返回做快照缓存", "implementation": "评测时使用缓存的证据库快照，避免实时 API 调用带来的漂移"}}, "metadata": {"query_used": "\"epigenetic regulation\" AND \"cardiovascular disease\" AND \"mechanism\" AND [Publication Date]", "question_type": "比较", "language": "en", "is_pagination_task": false, "evidence_snapshot_time": "2025-12-15T17:02:31.585429", "total_papers_available": 32, "num_tool_rubrics": 4, "num_content_rubrics": 5}}
{"sample_id": "pubmed_00012", "user_question": "在心血管疾病的研究中，哪些表观遗传机制被认为是关键的调控因素，并且目前有哪些临床试验正在针对这些机制进行研究？", "expected_tools": [{"tool_name": "pubmed_search", "parameters": {"keywords": "\"epigenetics\" AND \"cardiovascular disease\" AND \"review\" AND [Publication Date]", "limit": 5, "offset": 0}, "purpose": "检索相关医学文献"}], "evidence_pmids": ["37277249", "35752619"], "evidence_requirements": [{"pmid": "37277249", "title": "How epigenetics impacts on human diseases.", "year": "2023", "venue": "European journal of internal medicine", "abstract_evidence_sentence": "", "url": "https://pubmed.ncbi.nlm.nih.gov/37277249/"}, {"pmid": "35752619", "title": "Epigenetic regulation in cardiovascular disease: mechanisms and advances in clinical trials.", "year": "2022", "venue": "Signal transduction and targeted therapy", "abstract_evidence_sentence": "Epigenetics is closely related to cardiovascular diseases. Genome-wide linkage and association analyses and candidate gene approaches illustrate the multigenic complexity of cardiovascular disease.", "url": "https://pubmed.ncbi.nlm.nih.gov/35752619/"}], "answer_rubric": {"tool_rubrics": [{"category": "tool_use", "title": "正确调用 pubmed_search", "description": "模型必须调用 pubmed_search 工具进行文献检索，参数格式正确", "weight": 3}, {"category": "tool_use", "title": "引用正确的 PMID", "description": "输出必须包含正确的 PMID（至少 2 个），与工具返回结果对齐", "weight": 3}, {"category": "tool_use", "title": "提供年份和期刊信息", "description": "每篇被引用文献必须给出发表年份(year)和期刊名称(venue)", "weight": 2}, {"category": "tool_use", "title": "摘要证据句对齐", "description": "每篇被引用文献必须给出至少 1 句摘要证据句，可从 abstract 中摘写或紧贴改写", "weight": 3}], "content_rubrics": [{"category": "content", "title": "表观遗传学对疾病的影响", "description": "模型应提到表观遗传学通过化学修饰影响基因表达，而不改变DNA序列，以及其对疾病易感性的深远影响。", "weight": 3}, {"category": "content", "title": "心血管疾病的表观遗传机制", "description": "模型应讨论DNA甲基化、组蛋白修饰和非编码RNA在心血管疾病发展和逆转中的重要性。", "weight": 3}, {"category": "content", "title": "表观遗传关键酶的靶向", "description": "模型应提到靶向DNA甲基转移酶、组蛋白甲基转移酶、组蛋白乙酰化酶和去乙酰化酶作为心血管疾病治疗的新途径。", "weight": 3}, {"category": "content", "title": "多基因复杂性分析", "description": "模型应提及全基因组关联分析和候选基因方法展示了心血管疾病的多基因复杂性。", "weight": 3}], "stability_strategy": {"strategy_type": "cache_snapshot", "description": "该样本依赖对 pubmed_search 返回做快照缓存", "implementation": "评测时使用缓存的证据库快照，避免实时 API 调用带来的漂移"}}, "metadata": {"query_used": "\"epigenetics\" AND \"cardiovascular disease\" AND \"review\" AND [Publication Date]", "question_type": "汇总", "language": "zh", "is_pagination_task": false, "evidence_snapshot_time": "2025-12-15T17:02:38.387551", "total_papers_available": 529, "num_tool_rubrics": 4, "num_content_rubrics": 4}}
{"sample_id": "pubmed_pag_00013", "user_question": "器官类器官在不同癌症类型中的药物筛选和疗效评估的系统性综述", "expected_tools": [{"tool_name": "pubmed_search", "parameters": {"keywords": "\"organoid culture\" AND \"drug screening\" AND (\"efficacy\" OR \"effectiveness\") AND", "limit": 5, "offset": 0}, "purpose": "检索相关医学文献"}, {"tool_name": "pubmed_search", "parameters": {"keywords": "\"organoid culture\" AND \"drug screening\" AND (\"efficacy\" OR \"effectiveness\") AND", "limit": 5, "offset": 5}, "purpose": "获取第 2 页结果"}], "evidence_pmids": ["35802820", "38533706", "40991260", "29180611", "35765706", "37292676", "33377106"], "evidence_requirements": [{"pmid": "35802820", "title": "Patient-derived renal cell carcinoma organoids for personalized cancer therapy.", "year": "2022", "venue": "Clinical and translational medicine", "abstract_evidence_sentence": "BACKGROUND\nKidney cancer is one of the most common solid tumors.", "url": "https://pubmed.ncbi.nlm.nih.gov/35802820/"}, {"pmid": "38533706", "title": "Establishment of patient-derived organoids for guiding personalized therapies in breast cancer patients.", "year": "2024", "venue": "International journal of cancer", "abstract_evidence_sentence": "Breast cancer has become the most commonly diagnosed cancer. The intra- and interpatient heterogeneity induced a considerable variation in treatment efficacy.", "url": "https://pubmed.ncbi.nlm.nih.gov/38533706/"}, {"pmid": "40991260", "title": "Integrating Circulating Tumor DNA Dynamics and Sequential Organoid Drug Screening Enhances Breast Cancer Treatment Efficacy.", "year": "2025", "venue": "Cancer research", "abstract_evidence_sentence": "Dynamic changes in circulating tumor DNA (ctDNA) variant allele frequency (VAF) reflect real-time therapeutic efficacy.", "url": "https://pubmed.ncbi.nlm.nih.gov/40991260/"}, {"pmid": "29180611", "title": "Screening drug effects in patient-derived cancer cells links organoid responses to genome alterations.", "year": "2017", "venue": "Molecular systems biology", "abstract_evidence_sentence": "Cancer drug screening in patient-derived cells holds great promise for personalized oncology and drug discovery but lacks standardization.", "url": "https://pubmed.ncbi.nlm.nih.gov/29180611/"}, {"pmid": "35765706", "title": "3D printed human organoids: High throughput system for drug screening and testing in current COVID-19 pandemic.", "year": "2022", "venue": "Biotechnology and bioengineering", "abstract_evidence_sentence": "In the current pandemic, scenario the world is facing a huge shortage of effective drugs and other prophylactic medicine to treat patients which created havoc in several countries with poor resources.", "url": "https://pubmed.ncbi.nlm.nih.gov/35765706/"}, {"pmid": "37292676", "title": "The landscape of drug sensitivity and resistance in sarcoma.", "year": "2023", "venue": "bioRxiv : the preprint server for biology", "abstract_evidence_sentence": "UNLABELLED\nSarcomas are a family of rare malignancies composed of over 100 distinct histological subtypes.", "url": "https://pubmed.ncbi.nlm.nih.gov/37292676/"}, {"pmid": "33377106", "title": "High-throughput drug screening of fine-needle aspiration-derived cancer organoids.", "year": "2020", "venue": "STAR protocols", "abstract_evidence_sentence": "Generation of fine-needle aspiration (FNA)-derived cancer organoids has allowed us to develop a number of downstream applications.", "url": "https://pubmed.ncbi.nlm.nih.gov/33377106/"}], "answer_rubric": {"tool_rubrics": [{"category": "tool_use", "title": "正确调用 pubmed_search", "description": "模型必须调用 pubmed_search 工具进行文献检索，参数格式正确", "weight": 3}, {"category": "tool_use", "title": "引用正确的 PMID", "description": "输出必须包含正确的 PMID（至少 2 个），与工具返回结果对齐", "weight": 3}, {"category": "tool_use", "title": "提供年份和期刊信息", "description": "每篇被引用文献必须给出发表年份(year)和期刊名称(venue)", "weight": 2}, {"category": "tool_use", "title": "摘要证据句对齐", "description": "每篇被引用文献必须给出至少 1 句摘要证据句，可从 abstract 中摘写或紧贴改写", "weight": 3}], "content_rubrics": [{"category": "content", "title": "肾癌类器官的个性化治疗", "description": "模型应该提到利用患者来源的肾癌类器官进行个性化癌症治疗的潜力，并指出其通过H&E染色、免疫荧光、全外显子测序、RNA测序和单细胞RNA测序进行表征。", "weight": 3}, {"category": "content", "title": "乳腺癌类器官的药物测试", "description": "模型应描述乳腺癌患者来源的类器官能否准确反映原发肿瘤的结构和生物特性，并探讨其在个性化药物反应预测中的应用前景。", "weight": 3}, {"category": "content", "title": "ctDNA动态与类器官药物筛选结合", "description": "模型应提到将循环肿瘤DNA动态变化与连续类器官药物筛选相结合以优化乳腺癌治疗的策略，并指出ctDNA清除与无病生存期改善的相关性。", "weight": 3}, {"category": "content", "title": "癌细胞培养对药物筛选的影响", "description": "模型需提及癌症药物筛选中，患者来源细胞的培养方式（传统单层或基质依赖性类器官培养）对药物效应和选择的影响。", "weight": 3}, {"category": "content", "title": "3D打印类器官在COVID-19药物筛选中的应用", "description": "模型应讨论3D打印人类类器官在COVID-19大流行期间作为高通量药物筛选和测试系统的应用及其在现有药物重新利用中的作用。", "weight": 3}, {"category": "content", "title": "肉瘤中药物敏感性与耐药性", "description": "模型应提到患者来源的肿瘤类器官在识别肉瘤有效治疗中的应用，并指出肉瘤的稀有性对临床试验带来的挑战。", "weight": 3}, {"category": "content", "title": "细针抽吸类器官的高通量筛选", "description": "模型应描述细针抽吸来源的癌症类器官在高通量药物筛选中的应用，并提到该方法适合快速筛选中等规模的药物/化合物库。", "weight": 3}], "stability_strategy": {"strategy_type": "cache_snapshot", "description": "该样本依赖对 pubmed_search 返回做快照缓存", "implementation": "评测时使用缓存的证据库快照，避免实时 API 调用带来的漂移"}}, "metadata": {"query_used": "\"organoid culture\" AND \"drug screening\" AND (\"efficacy\" OR \"effectiveness\") AND", "question_type": "文献综述", "language": "zh", "is_pagination_task": true, "evidence_snapshot_time": "2025-12-15T17:02:41.928355", "total_papers_available": 20, "num_tool_rubrics": 4, "num_content_rubrics": 7}}
{"sample_id": "pubmed_00014", "user_question": "How do nanomaterials enhance the effectiveness of organoid cultures in drug screening across different types of diseases, including liver and colorectal cancer?", "expected_tools": [{"tool_name": "pubmed_search", "parameters": {"keywords": "\"organoid culture\" AND \"drug screening\" AND \"mechanism\" AND AND", "limit": 5, "offset": 0}, "purpose": "检索相关医学文献"}], "evidence_pmids": ["41210600", "40549302", "31086460"], "evidence_requirements": [{"pmid": "41210600", "title": "Application of nanomaterials in organoid culture and cryopreservation.", "year": "2025", "venue": "Nanoscale advances", "abstract_evidence_sentence": "", "url": "https://pubmed.ncbi.nlm.nih.gov/41210600/"}, {"pmid": "40549302", "title": "Precision medicine research progress based on colorectal cancer organoids.", "year": "2025", "venue": "Discover oncology", "abstract_evidence_sentence": "", "url": "https://pubmed.ncbi.nlm.nih.gov/40549302/"}, {"pmid": "31086460", "title": "Organoids of liver diseases: From bench to bedside.", "year": "2019", "venue": "World journal of gastroenterology", "abstract_evidence_sentence": "Understanding the occurrence, development, and treatment of liver diseases is the main goal of hepatopathology research.", "url": "https://pubmed.ncbi.nlm.nih.gov/31086460/"}], "answer_rubric": {"tool_rubrics": [{"category": "tool_use", "title": "正确调用 pubmed_search", "description": "模型必须调用 pubmed_search 工具进行文献检索，参数格式正确", "weight": 3}, {"category": "tool_use", "title": "引用正确的 PMID", "description": "输出必须包含正确的 PMID（至少 2 个），与工具返回结果对齐", "weight": 3}, {"category": "tool_use", "title": "提供年份和期刊信息", "description": "每篇被引用文献必须给出发表年份(year)和期刊名称(venue)", "weight": 2}, {"category": "tool_use", "title": "摘要证据句对齐", "description": "每篇被引用文献必须给出至少 1 句摘要证据句，可从 abstract 中摘写或紧贴改写", "weight": 3}], "content_rubrics": [{"category": "content", "title": "纳米材料在类器官培养中的应用", "description": "模型应提到纳米材料通过调节微环境和先进的工程培养技术，增强了类器官的构建和保存。", "weight": 3}, {"category": "content", "title": "肝病类器官的研究进展", "description": "模型应提到三维细胞培养技术在肝病研究中的应用，包括多能干细胞和成体干细胞的使用。", "weight": 3}, {"category": "content", "title": "纳米材料的生物相容性", "description": "模型应提到纳米材料具有独特的表面特性和优异的生物相容性，这使其成为生物医学研究中的重要工具。", "weight": 3}, {"category": "content", "title": "结直肠癌类器官的个体化治疗", "description": "模型应提到患者来源的结直肠癌类器官在个体化治疗中的应用价值。", "weight": 3}, {"category": "content", "title": "类器官在高通量药物筛选中的应用", "description": "模型应提到类器官因其易于构建和长期稳定传代，适用于高通量药物筛选。", "weight": 3}], "stability_strategy": {"strategy_type": "cache_snapshot", "description": "该样本依赖对 pubmed_search 返回做快照缓存", "implementation": "评测时使用缓存的证据库快照，避免实时 API 调用带来的漂移"}}, "metadata": {"query_used": "\"organoid culture\" AND \"drug screening\" AND \"mechanism\" AND AND", "question_type": "汇总", "language": "en", "is_pagination_task": false, "evidence_snapshot_time": "2025-12-15T17:02:45.459239", "total_papers_available": 8, "num_tool_rubrics": 4, "num_content_rubrics": 5}}
{"sample_id": "pubmed_00015", "user_question": "How do organoid culture methods and their applications in drug screening differ between pancreatic ductal adenocarcinoma and breast cancer according to recent studies?", "expected_tools": [{"tool_name": "pubmed_search", "parameters": {"keywords": "\"organoid culture\" AND \"drug screening\" AND \"review\" AND", "limit": 5, "offset": 0}, "purpose": "检索相关医学文献"}], "evidence_pmids": ["35004672", "37709150"], "evidence_requirements": [{"pmid": "35004672", "title": "Microfluidic Platforms for High-Throughput Pancreatic Ductal Adenocarcinoma Organoid Culture and Drug Screening.", "year": "2021", "venue": "Frontiers in cell and developmental biology", "abstract_evidence_sentence": "Pancreatic Ductal Adenocarcinoma (PDAC), the most common pancreatic cancer type, is believed to become the second leading cause of cancer-related deaths by 2030 with mortality rates of up to 93%.", "url": "https://pubmed.ncbi.nlm.nih.gov/35004672/"}, {"pmid": "37709150", "title": "Breast cancer organoids derived from patients: A platform for tailored drug screening.", "year": "2023", "venue": "Biochemical pharmacology", "abstract_evidence_sentence": "Breast cancer stands as the most prevalent and heterogeneous malignancy affecting women globally, posing a substantial health concern.", "url": "https://pubmed.ncbi.nlm.nih.gov/37709150/"}], "answer_rubric": {"tool_rubrics": [{"category": "tool_use", "title": "正确调用 pubmed_search", "description": "模型必须调用 pubmed_search 工具进行文献检索，参数格式正确", "weight": 3}, {"category": "tool_use", "title": "引用正确的 PMID", "description": "输出必须包含正确的 PMID（至少 2 个），与工具返回结果对齐", "weight": 3}, {"category": "tool_use", "title": "提供年份和期刊信息", "description": "每篇被引用文献必须给出发表年份(year)和期刊名称(venue)", "weight": 2}, {"category": "tool_use", "title": "摘要证据句对齐", "description": "每篇被引用文献必须给出至少 1 句摘要证据句，可从 abstract 中摘写或紧贴改写", "weight": 3}], "content_rubrics": [{"category": "content", "title": "PDAC高通量微流控平台", "description": "模型应提到微流控平台在PDAC类器官培养和药物筛选中的高通量应用，以应对PDAC的高致死率和化疗需求。", "weight": 3}, {"category": "content", "title": "PDAC类器官的化疗应用", "description": "模型应讨论PDAC类器官在化疗中的应用，尤其是由于其高密度基质和缺氧条件导致的治疗挑战。", "weight": 3}, {"category": "content", "title": "乳腺癌类器官的个性化药物筛选", "description": "模型应该提到乳腺癌类器官的开发来自患者样本，并用于个性化药物筛选的平台优势。", "weight": 3}, {"category": "content", "title": "乳腺癌类器官的三维培养优势", "description": "模型应描述三维类器官培养技术在克服传统体内模型和细胞培养技术的局限性方面的优势。", "weight": 3}, {"category": "content", "title": "PDAC和乳腺癌类器官的应用差异", "description": "模型应对比PDAC和乳腺癌类器官在药物筛选应用上的差异，特别是技术平台和个性化治疗的不同。", "weight": 3}], "stability_strategy": {"strategy_type": "cache_snapshot", "description": "该样本依赖对 pubmed_search 返回做快照缓存", "implementation": "评测时使用缓存的证据库快照，避免实时 API 调用带来的漂移"}}, "metadata": {"query_used": "\"organoid culture\" AND \"drug screening\" AND \"review\" AND", "question_type": "比较", "language": "en", "is_pagination_task": false, "evidence_snapshot_time": "2025-12-15T17:02:49.011319", "total_papers_available": 76, "num_tool_rubrics": 4, "num_content_rubrics": 5}}
{"sample_id": "pubmed_00016", "user_question": "外泌体在神经退行性疾病和自闭症谱系障碍的诊断和治疗中作为生物标志物的作用有什么异同？", "expected_tools": [{"tool_name": "pubmed_search", "parameters": {"keywords": "\"exosomes\" AND \"neurological diseases\" AND \"biomarkers\" AND \"diagnosis\" AND (\"therapy\" OR \"treatment\") AND ()", "limit": 5, "offset": 0}, "purpose": "检索相关医学文献"}], "evidence_pmids": ["30203797", "39503812"], "evidence_requirements": [{"pmid": "30203797", "title": "Effect of Regulatory Network of Exosomes and microRNAs on Neurodegenerative Diseases.", "year": "2018", "venue": "Chinese medical journal", "abstract_evidence_sentence": "", "url": "https://pubmed.ncbi.nlm.nih.gov/30203797/"}, {"pmid": "39503812", "title": "MicroRNAs as Regulators, Biomarkers, and Therapeutic Targets in Autism Spectrum Disorder.", "year": "2025", "venue": "Molecular neurobiology", "abstract_evidence_sentence": "The pathogenesis of autism spectrum disorder (ASD) is complex and is mainly influenced by genetic and environmental factors.", "url": "https://pubmed.ncbi.nlm.nih.gov/39503812/"}], "answer_rubric": {"tool_rubrics": [{"category": "tool_use", "title": "正确调用 pubmed_search", "description": "模型必须调用 pubmed_search 工具进行文献检索，参数格式正确", "weight": 3}, {"category": "tool_use", "title": "引用正确的 PMID", "description": "输出必须包含正确的 PMID（至少 2 个），与工具返回结果对齐", "weight": 3}, {"category": "tool_use", "title": "提供年份和期刊信息", "description": "每篇被引用文献必须给出发表年份(year)和期刊名称(venue)", "weight": 2}, {"category": "tool_use", "title": "摘要证据句对齐", "description": "每篇被引用文献必须给出至少 1 句摘要证据句，可从 abstract 中摘写或紧贴改写", "weight": 3}], "content_rubrics": [{"category": "content", "title": "外泌体形成机制", "description": "描述外泌体和microRNAs在神经退行性疾病中的形成机制以及其在生物标志物搜索中的作用。", "weight": 3}, {"category": "content", "title": "miRNAs在ASD中的角色", "description": "解释microRNAs如何作为自闭症谱系障碍的调节因子、生物标志物和治疗靶点。", "weight": 3}, {"category": "content", "title": "基因与环境的相互作用", "description": "讨论在自闭症谱系障碍中，microRNAs如何解释遗传因素与环境因素之间的联系。", "weight": 3}, {"category": "content", "title": "外泌体miRNA的排序机制", "description": "详细说明外泌体中miRNA的排序机制及其在神经退行性疾病中的潜在应用。", "weight": 3}, {"category": "content", "title": "miRNAs与神经疾病的关联", "description": "指出miRNAs与神经疾病的密切关联，特别是在自闭症谱系障碍中的异常表达情况。", "weight": 3}], "stability_strategy": {"strategy_type": "cache_snapshot", "description": "该样本依赖对 pubmed_search 返回做快照缓存", "implementation": "评测时使用缓存的证据库快照，避免实时 API 调用带来的漂移"}}, "metadata": {"query_used": "\"exosomes\" AND \"neurological diseases\" AND \"biomarkers\" AND \"diagnosis\" AND (\"therapy\" OR \"treatment\") AND ()", "question_type": "比较", "language": "zh", "is_pagination_task": false, "evidence_snapshot_time": "2025-12-15T17:03:01.492826", "total_papers_available": 14, "num_tool_rubrics": 4, "num_content_rubrics": 5}}
{"sample_id": "pubmed_00017", "user_question": "在神经退行性疾病中，外泌体与 microRNA 的调控网络如何影响疾病的生物标志物发现及治疗？", "expected_tools": [{"tool_name": "pubmed_search", "parameters": {"keywords": "\"exosomes\" AND \"neurological diseases\" AND \"biomarkers\" AND \"mechanism\" AND ()", "limit": 5, "offset": 0}, "purpose": "检索相关医学文献"}], "evidence_pmids": ["30203797", "30179121"], "evidence_requirements": [{"pmid": "30203797", "title": "Effect of Regulatory Network of Exosomes and microRNAs on Neurodegenerative Diseases.", "year": "2018", "venue": "Chinese medical journal", "abstract_evidence_sentence": "", "url": "https://pubmed.ncbi.nlm.nih.gov/30203797/"}, {"pmid": "30179121", "title": "The Mechanism of Exosomes Function in Neurological Diseases: A Progressive Review.", "year": "2018", "venue": "Current pharmaceutical design", "abstract_evidence_sentence": "", "url": "https://pubmed.ncbi.nlm.nih.gov/30179121/"}], "answer_rubric": {"tool_rubrics": [{"category": "tool_use", "title": "正确调用 pubmed_search", "description": "模型必须调用 pubmed_search 工具进行文献检索，参数格式正确", "weight": 3}, {"category": "tool_use", "title": "引用正确的 PMID", "description": "输出必须包含正确的 PMID（至少 2 个），与工具返回结果对齐", "weight": 3}, {"category": "tool_use", "title": "提供年份和期刊信息", "description": "每篇被引用文献必须给出发表年份(year)和期刊名称(venue)", "weight": 2}, {"category": "tool_use", "title": "摘要证据句对齐", "description": "每篇被引用文献必须给出至少 1 句摘要证据句，可从 abstract 中摘写或紧贴改写", "weight": 3}], "content_rubrics": [{"category": "content", "title": "外泌体的基本特征", "description": "模型应描述外泌体是细胞分泌的微粒，直径约为30-100纳米，包含蛋白质、RNA和脂质等生物信息。", "weight": 3}, {"category": "content", "title": "外泌体在神经疾病中的作用", "description": "模型应提到外泌体在神经疾病中促进细胞间通讯，并与血管生成和神经发生的调节密切相关。", "weight": 3}, {"category": "content", "title": "外泌体和miRNA的调控网络", "description": "模型应说明外泌体和microRNAs的调控网络在神经退行性疾病中的作用，特别是其在生物标志物发现和治疗中的潜力。", "weight": 3}, {"category": "content", "title": "外泌体的形成机制", "description": "模型应提及外泌体形成的机制，包括其在神经退行性疾病中的重要性。", "weight": 3}, {"category": "content", "title": "外泌体miRNA的排序机制", "description": "模型应讨论外泌体miRNA的排序机制，以及其在神经退行性疾病中的研究现状。", "weight": 3}, {"category": "content", "title": "研究方法与数据来源", "description": "模型应提到研究中使用的文献数据库，如NCBI PubMed和Web of Science，以及关键词选择的策略。", "weight": 3}], "stability_strategy": {"strategy_type": "cache_snapshot", "description": "该样本依赖对 pubmed_search 返回做快照缓存", "implementation": "评测时使用缓存的证据库快照，避免实时 API 调用带来的漂移"}}, "metadata": {"query_used": "\"exosomes\" AND \"neurological diseases\" AND \"biomarkers\" AND \"mechanism\" AND ()", "question_type": "汇总", "language": "zh", "is_pagination_task": false, "evidence_snapshot_time": "2025-12-15T17:03:05.037917", "total_papers_available": 4, "num_tool_rubrics": 4, "num_content_rubrics": 6}}
{"sample_id": "pubmed_00018", "user_question": "在神经性疾病中，外泌体非编码RNA如何通过小胶质细胞介导的细胞间通讯影响疾病进程，并与特定的淀粉样病理特征有何关联？", "expected_tools": [{"tool_name": "pubmed_search", "parameters": {"keywords": "\"exosomes\" AND \"neurological diseases\" AND \"biomarkers\" AND \"epidemiology\" AND ()", "limit": 5, "offset": 0}, "purpose": "检索相关医学文献"}], "evidence_pmids": ["39823800", "39841474"], "evidence_requirements": [{"pmid": "39823800", "title": "The roles and therapeutic potential of exosomal non-coding RNAs in microglia-mediated intercellular communication.", "year": "2025", "venue": "International immunopharmacology", "abstract_evidence_sentence": "Exosomes, which are small extracellular vesicles (sEVs), serve as versatile regulators of intercellular communication in the progression of various diseases, including neurological disorders.", "url": "https://pubmed.ncbi.nlm.nih.gov/39823800/"}, {"pmid": "39841474", "title": "Cerebral Microbleeds and Amyloid Pathology Estimates From the Amyloid Biomarker Study.", "year": "2025", "venue": "JAMA network open", "abstract_evidence_sentence": "", "url": "https://pubmed.ncbi.nlm.nih.gov/39841474/"}], "answer_rubric": {"tool_rubrics": [{"category": "tool_use", "title": "正确调用 pubmed_search", "description": "模型必须调用 pubmed_search 工具进行文献检索，参数格式正确", "weight": 3}, {"category": "tool_use", "title": "引用正确的 PMID", "description": "输出必须包含正确的 PMID（至少 2 个），与工具返回结果对齐", "weight": 3}, {"category": "tool_use", "title": "提供年份和期刊信息", "description": "每篇被引用文献必须给出发表年份(year)和期刊名称(venue)", "weight": 2}, {"category": "tool_use", "title": "摘要证据句对齐", "description": "每篇被引用文献必须给出至少 1 句摘要证据句，可从 abstract 中摘写或紧贴改写", "weight": 3}], "content_rubrics": [{"category": "content", "title": "外泌体在疾病中的作用", "description": "模型回答应提到外泌体作为小型细胞外囊泡在神经性疾病进程中的调节作用。", "weight": 3}, {"category": "content", "title": "非编码RNA的调控作用", "description": "模型回答应提到外泌体中的非编码RNA在病理生理过程中扮演的关键调控角色。", "weight": 3}, {"category": "content", "title": "小胶质细胞的交互作用", "description": "模型回答需提到外泌体非编码RNA在小胶质细胞介导的细胞间通讯中的作用。", "weight": 3}, {"category": "content", "title": "淀粉样病理特征", "description": "模型回答应提到淀粉样病理特征与脑微出血及APOE ε4等因素的关联。", "weight": 3}, {"category": "content", "title": "APOE ε4与淀粉样病理", "description": "模型回答应提到APOE ε4等位基因拷贝数与淀粉样病理状态之间的关联。", "weight": 3}, {"category": "content", "title": "脑微出血的风险因素", "description": "模型回答需提到脑微出血作为阿尔茨海默病患者淀粉样相关影像异常的风险因素。", "weight": 3}], "stability_strategy": {"strategy_type": "cache_snapshot", "description": "该样本依赖对 pubmed_search 返回做快照缓存", "implementation": "评测时使用缓存的证据库快照，避免实时 API 调用带来的漂移"}}, "metadata": {"query_used": "\"exosomes\" AND \"neurological diseases\" AND \"biomarkers\" AND \"epidemiology\" AND ()", "question_type": "汇总", "language": "zh", "is_pagination_task": false, "evidence_snapshot_time": "2025-12-15T17:03:08.237443", "total_papers_available": 2, "num_tool_rubrics": 4, "num_content_rubrics": 6}}
